Vertical Aerospace VX4 program moves to the next phase
15 Sep 2023
Photo Credit: Vertical Aerospace
Vertical Aerospace (London, U.K.) has provide an update on its overall program including a flight test update, addressing the unexpected fault that occurred earlier in August and where the company is at in regard to its program timeline.
Vertical concluded its remote thrustborne flight test campaign in July 2023, as the first full-scale VX4 electic vertical takeoff and landing (eVTOL) aircraft prototype reached its target speed of 70 kilometers per hour, demonstrating exceptional overall stability and control. Performance targets were generally exceeded by 10-30% during hover and low-speed flights. The company says the prototype performed especially well in sustained hover, typically the most challenging regime for a VTOL aircraft, where it maintained level flight for longer than anticipated. The aim of these thrustborne flight tests was to verify acceptable stability, battery efficiency and control characteristics, aerodynamics, structural loads, performance and vibration throughout this speed range — all of which were achieved.
Vertical continued further uncrewed flight tests following the completion of the remote thrustborne flight test campaign. The purpose of these was to understand how the aircraft performed outside of its expected operating conditions before the aircraft’s planned retirement.
During one of these test flights, an unexpected fault occurred causing the aircraft to enter a stable descent, before being damaged on impact with the ground. Vertical completed a swift and thorough investigation and submitted a report to the Air Accidents Investigation Branch (AAIB). The company’s investigation identified the root cause to be a fault with a propeller. This early generation propeller had already been redesigned prior to the incident, with the issue fully resolved ahead of the next phase of testing. Further recommendations by the investigation are being implemented by Vertical.
Vertical believes transparency and openness is fundamental to the safety of aerospace. It therefore intends to provide a further full update to the industry on the incident once the AAIB’s investigation has concluded.
Supported by the learnings from the completed thrustborne campaign, the VX4 and its certification program remains on track with no changes to timelines. The assembly of a second significantly more advanced full-scale VX4 prototype is underway at GKN Aerospace’s Global Technology Centre in Bristol., U.K. This demonstrator is expected to be ready to fly in early 2024. Its components will include technology from most of Vertical’s certification partners: Honeywell, GKN Aerospace, Hanwha, Solvay, Leonardo and Molicel. An additional, identical full-scale aircraft has also now been approved and is expected to be flying in the second half of 2024.
These upgraded full-scale aircrafts’ structures and subsystems will be tested in line with certification standards. Both will require rigorous regulatory oversight, including a Permit to Fly from the UK Civil Aviation Authority, to progress to piloted flying.
“We are pleased with our flight test progress to date and the data, insights and invaluable learnings we have collected,” Stephen Fitzpatrick, Vertical founder and CEO, says. “While a fault of any sort is disappointing, it is not wholly unexpected at this stage of testing a novel aircraft. I am pleased that as a result of our expert team we have isolated the cause of the fault and been able to provide the AAIB with our report within 14 days of the incident. Our planned second upgraded prototype, which will include most of our top Tier partners’ technology, will have us in the air early next year and we remain on track for our certification timelines.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.